CA2383371A1 - P193 proteins and nucleic acids, and uses thereof - Google Patents

P193 proteins and nucleic acids, and uses thereof Download PDF

Info

Publication number
CA2383371A1
CA2383371A1 CA002383371A CA2383371A CA2383371A1 CA 2383371 A1 CA2383371 A1 CA 2383371A1 CA 002383371 A CA002383371 A CA 002383371A CA 2383371 A CA2383371 A CA 2383371A CA 2383371 A1 CA2383371 A1 CA 2383371A1
Authority
CA
Canada
Prior art keywords
leu
glu
pro
arg
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002383371A
Other languages
English (en)
French (fr)
Inventor
Loren J. Field
Shih-Chong Tsai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indiana University Research and Technology Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2383371A1 publication Critical patent/CA2383371A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA002383371A 1999-08-23 2000-08-23 P193 proteins and nucleic acids, and uses thereof Abandoned CA2383371A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15026699P 1999-08-23 1999-08-23
US60/150,266 1999-08-23
PCT/US2000/023161 WO2001014418A2 (en) 1999-08-23 2000-08-23 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF

Publications (1)

Publication Number Publication Date
CA2383371A1 true CA2383371A1 (en) 2001-03-01

Family

ID=22533769

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002383371A Abandoned CA2383371A1 (en) 1999-08-23 2000-08-23 P193 proteins and nucleic acids, and uses thereof

Country Status (6)

Country Link
EP (1) EP1212418A2 (ja)
JP (1) JP2003520025A (ja)
AU (1) AU6930100A (ja)
CA (1) CA2383371A1 (ja)
IL (1) IL148286A0 (ja)
WO (1) WO2001014418A2 (ja)

Also Published As

Publication number Publication date
JP2003520025A (ja) 2003-07-02
WO2001014418A3 (en) 2002-02-14
AU6930100A (en) 2001-03-19
WO2001014418A2 (en) 2001-03-01
IL148286A0 (en) 2002-09-12
EP1212418A2 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
JP4790624B2 (ja) 生体分子パーティションモチーフ及びそれらの使用
KR100499600B1 (ko) 신생 세포 성장을 억제하기 위한 방법 및 조성물
JP2003116588A (ja) ポリペプチド及び同じものをコードしている核酸
CA2432111A1 (en) Jfy1 protein induces rapid apoptosis
KR100553300B1 (ko) 혈관신생 및 심혈관형성의 촉진 또는 억제 방법
JP2012065671A (ja) Ｍａｃａｃａｆａｓｃｉｃｕｌａｒｉｓ由来のＰ−糖タンパク質およびその使用
EP0871725B1 (en) P15 melanoma antigens and their use in diagnostic and therapeutic methods
US6534061B1 (en) Tumor necrosis factor receptor homologs and nucleic acids encoding the same
SK8482002A3 (en) Polynucleotid encoding the RG1 polypeptide
CA2363621A1 (en) A novel inhibitor of programmed cell death
US20030073236A1 (en) p193 proteins and nucleic acids, and uses thereof
CA2383371A1 (en) P193 proteins and nucleic acids, and uses thereof
US5955579A (en) Islet-specific homeoprotein and transcriptional regulator of insulin gene expression, HOXB13
KR20010085816A (ko) 면역 관련 질환 치료용 조성물 및 치료 방법
KR100448426B1 (ko) 신생 세포 성장을 억제하기 위한 방법 및 조성물
US7608698B2 (en) Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
US20040241797A1 (en) Use of alphacp1, alphacp2, and hur for modulating gene expression and inducing angiogenesis
US6746867B1 (en) Mammalian mesoderm induction early response (MIER) gene family
KR100678523B1 (ko) Pro840 폴리펩티드 아고니스트 또는 길항제의 확인 방법
ES2222959T3 (es) Polipeptidos pro241 y acido nucleico codificante de los mismos.
ES2267654T3 (es) Polipeptido y acidos nucleicos que lo codifican.
CA2225180A1 (en) Non-mammalian mesoderm induction early response (mier) gene family
JP2002526075A (ja) Ｕｃｐ４
US20040077832A1 (en) Jfy1protein induces rapid apoptosis
MXPA00005354A (en) Polypeptides and nucleic acids encoding the same

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued